Exelixis, Inc. provided earnings guidance for the fiscal year 2024. For the year, company expects Total revenues to be $1,825 million - $1,925 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.1 USD | +0.64% |
|
-1.65% | -7.88% |
07-04 | ANALYST RECOMMENDATIONS : Citigroup, Constellation Brands, Broadcom, JPMorgan, Bunzl... | ![]() |
07-02 | Ipsen Expands Partnership with Exelixis for Cabometyx | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.88% | 6.44B | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Exelixis, Inc. Provides Earnings Guidance for Fiscal Year 2024